Net gamma exposure for Denali Therapeutics Inc (DNLI) options was negative at the Nov 4, 2026 close, about $1.17K per 1% move in the stock. It has been positive on 6 of the last 20 trading days. With negative gamma, dealer hedging tends to follow price moves, which can make swings larger.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for DNLI, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for DNLI, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for DNLI, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
DNLI Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is DNLI gamma exposure positive or negative?
Denali Therapeutics net gamma exposure was negative on Nov 4, 2026, at -$1.17K. It has been positive on 6 of the last 20 trading days.
How has DNLI gamma exposure changed recently?
Denali Therapeutics net gamma exposure went from $4.59K on Oct 7, 2026 to -$1.17K on Nov 4, 2026. See the DNLI gamma exposure history for a longer view.
What is Denali Therapeutics Inc?
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases.